Casey DA, Rodriguez M, Northcott C, Vickar G, Shihabuddin L: Schizophrenia: medical illness, mortality, and aging. Int J Psychiatry Med. 2011, 41: 245-51. 10.2190/PM.41.3.c.
Wildgust HJ, Hodgson R, Beary M: The paradox of premature mortality in schizophrenia: new research questions. J Psychopharmacol. 2010, 24: 9-15. 10.1177/1359786810382149.
Copeland LA, Zeber JE, Rosenheck RA, Miller AL: Unforeseen inpatient mortality among veterans with schizophrenia. Med Care. 2006, 44: 110-6. 10.1097/01.mlr.0000196973.99080.fb.
Bouza C, Lopez-Cuadrado T, Amate JM: Hospital admissions due to physical disease in people with schizophrenia: a national population-based study. Gen Hosp Psychiatry. 2010, 32: 156-63. 10.1016/j.genhosppsych.2009.11.014.
Weber NS, Cowan DN, Millikan AM, Niebuhr DW: Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey. Psychiatr Serv. 2009, 60: 1059-67. 10.1176/appi.ps.60.8.1059.
Lambert TJ, Velakoulis D, Pantelis C: Medical comorbidity in schizophrenia. Med J Aust. 2003, 178 (Suppl): S67-70.
Brown S, Inskip H, Barraclough B: Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000, 177: 212-7. 10.1192/bjp.177.3.212.
APA: Practice guideline for the treatment of patients with schizophrenia, 2nd Edition. 2004, Arlington, VA
Falissard B, Mauri M, Shaw K, Wetterling T, Doble A, Giudicelli A, De Hert M: The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs. Int Clin Psychopharmacol. 2011, 26: 291-302. 10.1097/YIC.0b013e32834a5bf6.
Meszaros ZS, Dimmock JA, Ploutz-Snyder R, Chauhan SV, Abdul-Malak Y, Middleton FA, Batki SL: Accuracy of self-reported medical problems in patients with alcohol dependence and co-occurring schizophrenia or schizoaffective disorder. Schizophr Res. 2011, 132: 190-3. 10.1016/j.schres.2011.07.033.
Jin H, Meyer JM, Jeste DV: Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res. 2004, 71: 195-212. 10.1016/j.schres.2004.03.024.
Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, Cope MB, Riley WT, Vreeland B, Hibbeln JR, Alpert JE: Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med. 2009, 36: 341-50. 10.1016/j.amepre.2008.11.020.
Copeland LA, Mortensen EM, Zeber JE, Pugh MJ, Restrepo MI, Dalack GW: Pulmonary disease among inpatient decedents: Impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007, 31: 720-6. 10.1016/j.pnpbp.2007.01.008.
Khatana SA, Kane J, Taveira TH, Bauer MS, Wu WC: Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. PLoS One. 2011, 6: e19298-10.1371/journal.pone.0019298.
Baker AL, Lubman DI, Hides H: Smoking and schizophrenia: treatment approaches within primary care. Primary Psychiatry. 2010, 17: 49-54.
Fuller BE, Rodriguez VL, Linke A, Sikirica M, Dirani R, Hauser P: Prevalence of liver disease in veterans with bipolar disorder or schizophrenia. Gen Hosp Psychiatry. 2011, 33: 232-7. 10.1016/j.genhosppsych.2011.03.006.
Copeland LA, Zeber JE, Wang CP, Parchman ML, Lawrence VA, Valenstein M, Miller AL: Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Serv Res. 2009, 9: 127-10.1186/1472-6963-9-127.
Veterans Health Administration: Re-engaging veterans with serious mental illness in treatment. 2012, VHA Directive 2012-002, Januarry 10, 2012. Washington DC. [http://www1.va.gov/vhapublications/ViewPublication.asp?pub_ID%20=%202476]. Accessed July 12
Blow FC, McCarthy JF, Valenstein M, Austin K, Gillon L: Care for Veterans with Psychosis in the VHA, FY04: 6th Annual National Psychosis Registry Report. 2005, VA National Serious Mental Illness Treatment Research and Evaluation Center [SMITREC]: Ann Arbor, MI
Blow FC, Ullman E, Barry KL, Bingham CR, Copeland LA, McCormick R, Van Stone W: Effectiveness of specialized treatment programs for veterans with serious and persistent mental illness: a three-year follow-up. Am J Orthopsychiatry. 2000, 70: 389-400.
Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon , Bingham CR, Stavenger T: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care. 2002, 40: 630-9. 10.1097/00005650-200208000-00002.
Sohn MW, Arnold N, Maynard C, Hynes DM: Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006, 4: 2-10.1186/1478-7954-4-2.
Shen Y, Hendricks A, Zhang S, Kazis LE: VHA enrollees' health care coverage and use of care. Med Care Res Rev. 2003, 60: 253-67. 10.1177/1077558703060002007.
Charlson M, Peterson JC: Medical comorbidity and late life depression: what is known and what are the unmet needs?. Biol Psychiatry. 2002, 52: 226-35. 10.1016/S0006-3223(02)01422-1.
Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-83. 10.1016/0021-9681(87)90171-8.
Selim AJ, Fincke G, Ren XS, Lee A, Rogers WH, Miller DR, Skinner KM, Linzer M, Kazis LE: Comorbidity assessments based on patient report: results from the Veterans Health Study. J Ambul Care Manage. 2004, 27: 281-95.
Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992, 45: 613-9. 10.1016/0895-4356(92)90133-8.
Pugh MJ, Copeland LA, Zeber JE, Cramer JA, Amuan ME, Cavazos JE, Kazis LE: The impact of epilepsy on health status among younger and older adults. Epilepsia. 2005, 46: 1820-7. 10.1111/j.1528-1167.2005.00291.x.
Aldenderfer M, Blashfield R: Cluster Analysis. 1984, Sage: Newbury Park, CA
Starfield B, Shi L, Macinko J: Contribution of primary care to health systems and health. Milbank Q. 2005, 83: 457-502. 10.1111/j.1468-0009.2005.00409.x.
Laursen TM, Munk-Olsen T, Gasse C: Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011, 6: e24597-10.1371/journal.pone.0024597.
Goldman LS: Medical illness in patients with schizophrenia. J Clin Psychiatry. 1999, 60 (Suppl 21): 10-5.
Copeland LA, Pugh MJ, Hicks PB, Noel PH: Use of obesity-related care by psychiatric patients. Psychiatric Services. 2012, 63: 230-236. 10.1176/appi.ps.201100221.
Schimming C, Harvey PD: Disability reduction in elderly patients with schizophrenia. J Psychiatr Pract. 2004, 10: 283-95. 10.1097/00131746-200409000-00002.
Harrow M, Jobe TH, Faull RN: Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study. Psychol Med. 2012, 1-11.
Maher AR, Theodore G: Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. J Manag Care Pharm. 2012, 18: S1-20.
Alexopoulos GS, Streim J, Carpenter D, Docherty JP: Using antipsychotic agents in older patients. J Clin Psychiatry. 2004, 65 (Suppl 2): 5-99. discussion 100-102; quiz 103-4
Giron M, Fernandez-Yanez A, Mana-Alvarenga S, Molina-Habas A, Nolasco A, Gomez-Beneyto M: Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study. Psychol Med. 2010, 40: 73-84. 10.1017/S0033291709006126.
Kilbourne AM, Morden NE, Austin K, Ilgen M, McCarthy JF, Dalack G, Blow FC: Excess heart-disease-related mortality in a national study of patients with mental disorders: identifying modifiable risk factors. Gen Hosp Psychiatry. 2009, 31: 555-63. 10.1016/j.genhosppsych.2009.07.008.
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005, 353: 1209-23. 10.1056/NEJMoa051688.
Mackin P: Cardiac side effects of psychiatric drugs. Hum Psychopharmacol. 2008, 23 (Suppl 1): 3-14.
Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP: Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol. 2007, 5: 508-12. 10.1016/j.cgh.2007.01.014.
Rosenheck R, Fontana A: Utilization of mental health services by minority veterans of the Vietnam era. J Nerv Ment Dis. 1994, 182: 685-91. 10.1097/00005053-199412000-00002.
Lucksted A, McFarlane W, Downing D, Dixon L: Recent developments in family psychoeducation as an evidence-based practice. J Marital Fam Ther. 2012, 38: 101-21. 10.1111/j.1752-0606.2011.00256.x.
Morgan RO, Teal CR, Reddy SG, Ford ME, Ashton CM: Measurement in Veterans Affairs Health Services Research: veterans as a special population. Health Serv Res. 2005, 40: 1573-83. 10.1111/j.1475-6773.2005.00448.x.
Jerant A, Fenton JJ, Franks P: Primary care attributes and mortality: a national person-level study. Ann Fam Med. 2012, 10: 34-41. 10.1370/afm.1314.
Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD: Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995, 15: 369-90. 10.1111/j.1539-6924.1995.tb00330.x.